$22.1 - LYEL | Lyell Immunopharma, Inc. Common Stock

Lyell Immunopharma, Inc. Common Stock (LYEL)

Lyell Immunopharma, Inc. Common Stock

XNAS:LYEL

22.1

-7.92%

Ask

$22.10 - 32.00

Bid

$21.67 - 58.00

Low

$22.01

High

$24.67

Open

$24.44

Prev Close

$24

52W High

25.2

52W Low

7.65

Volume

50090

Avg Vol (3m)

49475.6

Float

6935699.13

Chart

TendieTensor AI Analysis

Company

Asset Type: Common Stock

SIC Code: 2834

Sector: Health Technology

Industry: Biotechnology

Date Listed: 06/17/2021

Primary Exchange: XNAS

Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.

Phone: 650 695-0677

Address: 201 Haskins Way

City: South San Francisco

State: CA

Postal Code: 94080

Website

TendieTensor AI Analyst Recommendation: —

Fundamentals

Total Employees:

300

P/E (TTM)

-0.960000

P/B (TTM)

1.406940

EPS

-2.13

Round Lot

100

Composit FIGI

BBG00RNXFN14

Share Class FIGI

BBG00RNXFN23

Share Class Shares Outstanding

19.21M

Weighted Shares Outstanding

19.21M

Technicals

RSI (14)

MACD Line

MACD Signal

SMA 20

SMA 50

EMA 50

Trend

Short Interest

—

Days to Cover

— —

Higher = harder to cover

Short Interest Δ

—

Prev: —

Short Volume Ratio (Today)

— —

5D avg: —

Squeeze Score (0–100)

—

Discussion